- Home
- BWFG vs RZLT Comparison
BWFG vs RZLT Comparison
Compare BWFG & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | RZLT |
|---|---|---|
| Founded | 2002 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.2M | 471.0M |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | BWFG | RZLT |
|---|---|---|
| Price | $67.27 | $3.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $69.50 | $9.80 |
| AVG Volume (30 Days) | 46.3K | ★ 1.7M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ 261.79 | 23.47 |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $2,826,000.00 | N/A |
| Revenue This Year | $19.65 | N/A |
| Revenue Next Year | $6.50 | $2,214.20 |
| P/E Ratio | $22.34 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $42.50 | $1.07 |
| 52 Week High | $69.59 | $11.46 |
Technical Indicators
Market Signals| Indicator | BWFG | RZLT |
|---|---|---|
| Relative Strength Index (RSI) | 57.56 | 39.02 |
| Support Level | $63.84 | $3.69 |
| Resistance Level | $69.22 | $4.09 |
| Average True Range (ATR) | 1.20 | 0.37 |
| MACD | 0.13 | -0.07 |
| Stochastic Oscillator | 78.53 | 24.03 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.